Trial
NCT00127036
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Roche Pharma AG
Condition
Adenocarcinoma
Intervention
XELOX
Why stopped
drug now on market
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-23